Navigation Links
EZChrom Elite from JASCO

ProductsEZChrom Elite from JASCO
Company JASCO
Item EZChrom Elite
Price 
Description 21 CFR part 11, Compliant software for JASCO HPLC systems.
Integrated Instrument Control
EZChrom Elite can be configured with a vast number of control software options for JASCO HPLC systems. This provides a completely integrated system to control instrument's operation, collect andstore results, and record all instrument settings with each run.
Comprehensive Data Analysis
EZChrom Elite has been continuously and regularly refined and enhanced for years from the experience of leading chromatography end users. This results in a software package that can flexiblyhandle all kinds of chromatography data requirements and demands. With anincredibly rich and comprehensive feature set, users can employ EZChrom Elitewith the confidence of knowing that they are using a powerful software package than can meet current and future laboratory needs.
Intelligent Data Acquisition and Automation
Core to the EZChrom Elitesystem is its built-in automation features and strong control of the dataacquisition process. It takes advantage of the latest tools in automation to allow conditional actions to be preprogrammed as part of the dataacquisition.
GLP/GMP Features
Users in regulated environments can utilize some ofthe most comprehensive features for GLP/GMP concerns. Complete audit trails and system logs to document and record all changes to the system, highly flexible user security for access and operational privileges, and electronic signatures and signoffs to handle the 21 CFR Part 11 requirements are justsome of the special features in EZChrom Elite.
Info JASCOJASCO
8649 Commerce Drive
Easton, MD 21601 USA

Customer Service: (410) 822-1220
Fax Number: (410) 822-7526
Web Site: http://www.jascoinc.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. FP-6500/6600 research-grade fluorescence spectrometers from JASCO
2. HV-2080-01 Column Switching Valve from JASCO
3. LV-2080 Solvent Switching Valve from JASCO
4. AS-2055/2057 Intelligent Autosampler from JASCO
5. Supercritical fluid chromatography and extraction systems (SFC/SFE) from JASCO
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally ... more evident than at international borders. Over the ... scanners have allowed veteran travelers to self process ... Control (APC) Kiosks at an increasing number of ... According to Maxine Most ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... researchers have discovered Salmonella bacteria that are up ... may help prevent food poisoning outbreaks that continue to plague ... can override vaccines and pose a risk to food safety ... strategies to find the more dangerous bugs were unsuccessful since ...
... CA April 18, 2012 Scientists at The Scripps ... mice from an otherwise lethal overdose of cocaine. The findings ... to reverse the effects of cocaine in case of emergency. ... about 5,000 overdose deaths each year in the United States. ...
... Maastricht, 17 April 2012 The Second European ... Netherlands, brings together high-level researchers, policymakers and practitioners to ... sectors of energy will share their ideas on how ... of environmental and climate impact and also in terms ...
Cached Biology News:UCSB researchers discover particularly dangerous Salmonella 2Scripps Research Institute scientists develop antidote for cocaine overdose 2Scripps Research Institute scientists develop antidote for cocaine overdose 3
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/19/2014)... Hershey, PA (PRWEB) December 19, 2014 ... a leading developer and manufacturer of needle-free injection ... an agreement with Immunomic Therapeutics, Inc. (“ITI”) for ... injection device with its LAMP™ vaccine platform. ... for an exclusive Worldwide license to the Biojector®-2000 ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3